Author

Ying Xie

Observed name: Xie, Ying

Institutions: Fujian Provincial Hospital, Shanxi Provincial People’s Hospital

Observed institutions: Fujian Medical University, Fujian Provincial Hospital, Shanxi Provincial People’s Hospital

ORCID: 0009-0005-6352-1174

Observed ORCID: 0009-0005-6352-1174

OpenAlex ID: A5010317857

Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China

2021 · Jie Zha, Liyuan Fan, et al. · Journal of Hematology & Oncology · 40

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

2022 · Jie Zha, Hui Zhou, et al. · Blood · 8

Percutaneous ultrasound-guided core needle biopsy for the diagnosis of cardiac tumors: Optimizing the treatment strategy for patients with intermural and pericardial cardiac tumors

2022 · Ying Xie, Zhi-liang Hong, et al. · Frontiers in Oncology · 7

A case report on clinical features, diagnosis, and treatment of rhino‐orbito‐cerebral mucormycosis

2023 · Jie‐Qiong Ding, Ying Xie · Immunity Inflammation and Disease · 6

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

2023 · Jie Zha, Ying Wang, et al. · Blood · 5

Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China

2022 · Zhijuan Lin, Jie Zha, et al. · Blood · 1

[Rituximab-Based Regimens for Treatment of Primary Gastric Diffuse Large B-Cell Lymphoma].

2022 · Shuang Qu, Li-Sheng Liao, et al. · PubMed · 1

Works count: 8

Citation count: 68

H-index: 5

I10-index: 1